RV-1521

N/A

Report date: 2026/05/13 09:11:30

Base Information

Drug NameRV-1521

Drug Alias NameKRAS mutations vaccine (RNAimmune)mRNA-1521RV-1521

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsColonic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRNAimmune Inc

China Registration ClassN/A

Develop Information

Active CompaniesRNAimmune Inc

Inactive CompaniesN/A

Active IndicationsColonic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A